We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+18.27%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.57B
AUM Growth
+$53.2M
(+3.5%)
Cap. Flow
-$106M
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
82.2%
Holding
38
New
3
Increased
3
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYBX
Synlogic
SYBX
|
+$18.8M |
| 2 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$15.4M |
| 3 |
Avalo Therapeutics
AVTX
|
+$2.27M |
| 4 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
+$1.87M |
| 5 |
AKTX
Akari Therapeutics
AKTX
|
+$1.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Supernus Pharmaceuticals
SUPN
|
+$107M |
| 2 |
MM
MILLENNIAL MEDIA INC COM STK (DE)
MM
|
+$14.4M |
| 3 |
TRVN
Trevena, Inc.
TRVN
|
+$10.7M |
| 4 |
CVT
CVENT, INC.
CVT
|
+$8.22M |
| 5 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$5.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.28% |
| 2 | Communication Services | 8.63% |
| 3 | Technology | 7.87% |
| 4 | Consumer Discretionary | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARQL
26
DELISTED
Arqule Inc
ARQL
| $5.47M | 0.35% |
2,520,316
| – | – |
|
|
ZSAN
27
DELISTED
Zosano Pharma Corporation
ZSAN
| $4.92M | 0.31% |
3,084
| – | – |
|
|
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
| $4.78M | 0.3% |
956,258
| – | – |
|
|
ROKA
29
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $3.96M | 0.25% |
322,043
| – | – |
|
|
PRTK
30
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.37M | 0.15% |
125,004
| – | – |
|
31
Gyre Therapeutics
GYRE
$641M
| $2.04M | 0.13% |
5,799
| – | – |
|
|
AKTX
32
Akari Therapeutics
AKTX
$13.8M
| $1.77M | 0.11% |
152
+118
| +347% | +$1.75M |
|
|
AGRX
33
DELISTED
Agile Therapeutics
AGRX
| $1.3M | 0.08% |
67
| – | – |
|
|
34
Avalo Therapeutics
AVTX
$965M
| $1.2M | 0.08% |
+207
| New | +$2.27M |
|
|
35
Supernus Pharmaceuticals
SUPN
$2.59B
| – | – |
-7,641,250
| Closed | -$107M |
|
|
ECOM
36
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| – | – |
-556,692
| Closed | -$5.53M |
|
|
CVT
37
DELISTED
CVENT, INC.
CVT
| – | – |
-244,106
| Closed | -$8.22M |
|
|
MM
38
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
| – | – |
-8,224,752
| Closed | -$14.4M |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
GD
NEA Management Company's Q4 2015 Portfolio in Review
As of Q4 2015, NEA Management Company held 38 positions worth $1.57B, up 3.5% from $1.52B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
NEA Management Company withdrew a net $106M in Q4 2015, closing 4 positions and reducing 1 holding. Its most notable exit was Supernus Pharmaceuticals, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 73% a quarter earlier, followed by Communication Services and Technology.
Against the trend, NEA Management Company opened a new position in Synlogic worth $18.6M.
- NEA Management Company's largest Q4 2015 buy was Synlogic: 28,332 shares worth $18.6M.
- NEA Management Company added most to Viracta Therapeutics, Inc. Common Stock in Q4 2015, an estimated $1.87M increase.
- NEA Management Company's biggest Q4 2015 reduction was Trevena, Inc., cutting an estimated $10.7M.
- NEA Management Company fully exited Supernus Pharmaceuticals in Q4 2015, selling an estimated $107M.
- NEA Management Company's ten largest holdings make up 82% of its $1.57B portfolio in Q4 2015.
- NEA Management Company opened 3 new positions and closed 4 in Q4 2015.
- NEA Management Company's portfolio value rose 3.5% quarter-over-quarter to $1.57B.
Based on NEA Management Company's 13F filing for Q4 2015, filed 22 Jan 2016.